billHR7692Event Wednesday, February 25, 2026Analyzed

Supreme Court Ethics and Investigations Act

Neutral

Summary

H.R. 7692, the Supreme Court Ethics and Investigations Act, has been introduced in the House and referred to the Judiciary Committee. It proposes creating new ethics and investigative offices within the Supreme Court but authorizes no direct spending, has no cosponsors beyond 10, and faces an uncertain path in the current Congress. No publicly traded companies are directly affected by the bill's provisions.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.H.R. 7692 is an early-stage, procedural bill with no direct spending or market impact.
  • 2.The bill creates internal ethics and investigative offices within the Supreme Court but does not affect any public company's revenue or costs.
  • 3.Low passage probability due to partisan sponsorship, no committee progress after four months, and absence of funding authorization or market mechanism.

Market Implications

No structural market implications. The bill does not create, fund, or regulate any industry or public company. Investors should disregard this legislation for portfolio decisions.

Full Analysis

On February 25, 2026, Representative Daniel S. Goldman (D-NY-10) introduced H.R. 7692, the Supreme Court Ethics and Investigations Act, in the 119th Congress. The bill was referred to the House Committee on the Judiciary, its only committee assignment. It seeks to amend Title 28 of the U.S. Code to establish an Office of Ethics Counsel and an Office of Investigative Counsel within the Supreme Court of the United States. The legislation is in an early stage—introduced and referred—with no further action recorded as of July 1, 2026.

The bill does not authorize any specific funding amount; it establishes positions (chief ethics counsel and supporting staff) with mandated salaries ($225,000 and $180,000 per year, respectively) but does not appropriate those sums. Actual funding would require a separate appropriations bill. The companion bill in the Senate, S. 3914, has also been introduced and referred to the Senate Judiciary Committee, providing a parallel track but no guarantee of advancement.

No publicly traded companies are directly impacted by the bill. The bill's focus is internal Supreme Court governance—ethics advice, disclosure guidance, and investigative functions for justices and their spouses. It does not create federal contracts, grant programs, tax incentives, or market-based mechanisms that would affect the revenues or operations of any corporation. The policy area is Law, not a GICS sector like Finance or Technology.

Looking forward, the bill must pass both the House Judiciary Committee and the full House, then the Senate Judiciary Committee and the full Senate, before reaching the President's desk. Given its narrow focus, partisan sponsorship (only Democratic cosponsors), and lack of committee advancement after four months, passage probability appears low in the 119th Congress. No market-relevant timeline exists for this procedural legislation.

Key Legislators

Rep. Goldman, Daniel S. [D-NY-10]

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →